Announcements

Eagle Point Credit Management LLC filed Amendment No. 5 to its Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of Preferred Shares of Carlyle Credit Income Fund as of September 30, 2026.

Opaleye Management Inc., Opaleye, L.P., and James Silverman filed an amended Schedule 13G with the SEC on November 6, 2026, disclosing their beneficial ownership of common stock in Gossamer Bio, Inc. as of September 30, 2026.

Opaleye Management Inc., Opaleye, L.P., and James Silverman filed an amended beneficial ownership statement with the SEC on November 6, 2026, disclosing that as of September 30, 2026, they collectively held zero shares of Pasithea Therapeutics Corp. common stock.

Opaleye Management Inc., Opaleye, L.P., and James Silverman filed Amendment No. 8 to their Schedule 13G on November 6, 2026, disclosing a combined beneficial ownership position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) as of September 30, 2026.

Karpus Management, Inc. filed an amended beneficial ownership statement on November 6, 2026, reporting a 15.83% stake in Melar Acquisition Corp. I/Cayman as of October 30, 2026.

Hexstone Capital LLC and its managing member Brendan O'Neil filed Amendment No. 1 to their Schedule 13G with the SEC on November 6, 2026, disclosing that their beneficial ownership of Jet.AI Inc. common stock has fallen below 5 percent, constituting an exit filing.

Eagle Point Credit Management LLC filed Amendment No. 8 to its beneficial ownership statement with the SEC on November 6, 2026, disclosing a 4.3% position in the Preferred Stock of OFS Credit Company, Inc. as of September 30, 2026.